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Abstract
This paper is devoted to the analysis of a mathematical model of blood cells produc-
tion in the bone marrow (hematopoiesis). The model is a system of two age-structured
partial differential equations. Integrating these equations over the age, we obtain a sys-
tem of two nonlinear differential equations with distributed time delay corresponding
to the cell cycle duration. This system describes the evolution of the total cell popula-
tions. By constructing a Lyapunov functional, it is shown that the trivial equilibrium
is globally asymptotically stable if it is the only equilibrium. It is also shown that the
nontrivial equilibrium, the most biologically meaningful one, can become unstable via a
Hopf bifurcation. Numerical simulations are carried out to illustrate the analytical re-
sults. The study maybe helpful in understanding the connection between the relatively
short cell cycle durations and the relatively long periods of peripheral cell oscillations
in some periodic hematological diseases.
Keywords: Blood cells, hematopoiesis, differential equations, distributed delay, asymptotic
stability, Lyapunov functional, Hopf bifurcation.
1 Introduction
Cellular population models have been investigated intensively since the 1960’s (see, for ex-
ample, Trucco [33, 34], Nooney [25], Rubinow [28] and Rubinow and Lebowitz [29]) and still
∗Research was partially supported by the NSERC of Canada and the College of Arts and Sciences
at the University of Miami.
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interest a lot of researchers. This interest is greatly motivated, on one hand, by the medi-
cal applications and, on the other hand, by the biological phenomena (such as oscillations,
bifurcations, traveling waves or chaos) observed in these models and, generally speaking, in
the living world (Mackey and Glass [19], Mackey and Milton [20]).
Hematopoiesis is the process by which primitive stem cells proliferate and differentiate to
produce mature blood cells. It is driven by highly coordinated patterns of gene expression
under the influence of growth factors and hormones. The regulation of hematopoiesis is about
the formation of blood cell elements in the body. White and red blood cells and platelets
are produced in the bone marrow from where they enter the blood stream. The principal
factor stimulating red blood cell production is the hormone produced in the kidney, called
erythropoietin. About 90% of the erythropoietin is secreted by renal tubular epithelial cells
when blood is unable to deliver sufficient oxygen. When the level of oxygen in the blood
decreases this leads to a release of a substance, which in turn causes an increase in the
release of the blood elements from the marrow. There is a feedback from the blood to the
bone marrow. Abnormalities in the feedback are considered as major suspects in causing
periodic hematological diseases, such as auto-immune hemolytic anemia (Bélair et al. [4] and
Mahaffy et al. [23]), cyclical neutropenia (Haurie et al. [14]), chronic myelogenous leukemia
(Fowler and Mackey [12] and Pujo-Menjouet et al. [26]), etc.
Cell biologists classified stem cells as proliferating cells and resting cells (also called G0-
cells) (see Mackey [16, 17]). Proliferating cells are committed to undergo mitosis a certain
time after their entrance into the proliferating phase. Mackey supposed that this time of
cytokinesis is constant, that is, it is the same for all cells. Most of committed stem cells
are in the proliferating phase. The G0-phase, whose existence is known due to the works of
Burns and Tannock [8], is a quiescent stage in the cellular development. However, it is usually
believed that 95% of pluripotent stem cells are in the resting phase. Resting cells can exit
randomly to either entry into the proliferating phase or be irremediably lost. Proliferating
cells can also be lost by apoptosis (programmed cell death).
The model of Mackey [16] has been numerically studied by Mackey and Rey [21] and
Crabb et al. [9]. Computer simulations showed that there exist strange behaviors of the stem
cell population, such as oscillations and bifurcations. Recently, Pujo-Menjouet and Mackey
[27] proved the existence of a Hopf bifurcation which causes periodic chronic myelogenous
leukemia and showed the great dependence of the model on the parameters.
In this paper, based on the model of Mackey [16], we propose a more general model
of hematopoiesis. We take into account the fact that a cell cycle has two phases, that
is, stem cells in process are either in a resting phase or actively proliferating. However,
we do not suppose that all cells divide at the same age, because this hypothesis is not
biologically reasonable. For example, it is believed that pluripotent stem cells divide faster
than committed stem cells, which are more mature cells. There are strong evidences (see
Bradford et al. [7]) that indicate that the age of cytokinesis τ is distributed on an interval
[τ , τ ] with τ ≥ 0. Hence, we shall assume that τ is distributed with a density f supported on
an interval [τ , τ ], with 0 ≤ τ < τ < +∞. The resulting model is a system of two differential
equations with distributed delay. A simpler model, dealing with the pluripotent stem cell
population behavior, has been studied by Adimy et al. [1].
Some results about stability of differential equations with distributed delay can be men-
tioned. In [6], Boese studied the stability of a differential equation with gamma-distributed
delay. Gamma distributions have the property to simplify the nature of the delay and this
situation is close to the one with discrete delay. Anderson [2, 3] showed stability results
linked to the different moments (especially the expectation and the variance) of the distri-
bution. Kuang [15] also obtained general stability results for systems of delay differential
equations. More recently, sufficient conditions for the stability of delay differential equations
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with distributed delay have been obtained by Bernard et al. [5]. They used some properties
of the distribution to prove these results. However, in all these works, the authors focused
on sufficient conditions for the stability, there is no necessary condition in these studies, and
these results are not applicable directly to the model considered in this paper.
This paper is organized as follows: in Section 2, we present the model and establish
boundedness properties of the solutions. In Section 3, we study the asymptotic stability of
the equilibria. We give conditions for the trivial equilibrium to be globally asymptotically
stable in Section 3.1 and investigate the stability of the nontrivial equilibrium in Section
3.2. In Section 4, we show that a local Hopf bifurcation occurs in our model. In Section 5,
numerical simulations are performed to demonstrate that our results can be used to explain
the long period oscillations observed in chronic myelogenous leukemia.
2 The hematopoiesis process: presentation of the model
Denote by r(t, a) and p(t, a) the population densities of resting an proliferating cells, respec-
tively, which have spent a time a ≥ 0 in their phase at time t ≥ 0. Resting cells can either
be lost randomly at a rate δ ≥ 0, which takes into account the cellular differentiation, or
entry into the proliferating phase at a rate β. Proliferating cells can be lost by apoptosis
(a programmed cell death) at a rate γ ≥ 0 and, at mitosis, cells with age a divide in two
daughter cells (which immediately enter the G0-phase) with a rate g(a).
The function g : [0, τ) → R+ satisfies g(a) = 0 if a < τ with 0 ≤ τ < τ < +∞. Moreover,
it is assumed to be piecewisely continuous such that
∫ τ
τ
g(a)da = +∞. The later assumption
describes the fact that cells which did not die have to divide before they reach the maximal
age τ .
The nature of the trigger signal for introduction in the proliferating phase is not clear.
However, the work of Sachs [30] shows that we can reasonably think that it strongly depends
on the entire resting cell population, that is β = β(x(t)), with
x(t) =
∫ +∞
0
r(t, a)da, t ≥ 0.
The function β is supposed to be continuous and positive. Furthermore, from a reasonable
biological point of view, we assume that β is decreasing with limx→+∞ β(x) = 0. This
describes the fact that the rate of re-entry into the proliferating compartment is a decreasing
function of the G0-phase population.
Usually, it is believed that the function β is a monotone decreasing Hill function (see
Mackey [16]), given by
β(x) = β0
θn
θn + xn
, x ≥ 0, (1)
with β0 > 0, θ ≥ 0 and n > 0. β0 is the maximal rate of re-entry in the proliferating phase,
θ is the number of resting cells at which β has its maximum rate of change with respect to
the resting phase population, and n describes the sensitivity of the reintroduction rate with
changes in the population.
The above parameters values are usually chosen (see Mackey [16]) to be
δ = 0.05 day−1, γ = 0.2 day−1, β0 = 1.77 day
−1 and n = 3. (2)
Although an usual value of θ is θ = 1.62× 108 cells/kg, it can be normalized without loss of
generality when one makes a qualitative analysis of the population.
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Then r(t, a) and p(t, a) satisfy the system of partial differential equations
∂r
∂t
+
∂r
∂a
= −
(
δ + β(x(t))
)
r, a > 0, t > 0, (3)
∂p
∂t
+
∂p
∂a
= −
(
γ + g(a)
)
p, 0 < a < τ, t > 0, (4)
with
r(0, a) = ν(a), a ≥ 0, p(0, a) = Γ(a), a ∈ [0, τ ].
The functions ν = ν(a) and Γ = Γ(a) give the population densities of cells which have spent
a time a in the resting and proliferating phase, respectively, at time t = 0; that is the initial
populations of cells with age a in each phase.
The boundary conditions of system (3)–(4), which describe the cellular flux between the
two phases, are given by



r(t, 0) = 2
∫ τ
τ
g(τ)p(t, τ)dτ,
p(t, 0) = β(x(t))x(t).
Moreover, we suppose that lima→+∞ r(t, a) = 0 and lima→τ p(t, a) = 0.
Let y(t) denote the total population density of proliferating cells at time t; then
y(t) =
∫ τ
0
p(t, a)da, t ≥ 0.
Thus, integrating (3) and (4) with respect to the age variable, we obtain
dx
dt
= −
(
δ + β(x(t))
)
x(t) + 2
∫ τ
τ
g(τ)p(t, τ)dτ, (5)
dy
dt
= −γy(t) + β(x(t))x(t) −
∫ τ
τ
g(τ)p(t, τ)dτ. (6)
We define a function G by
G(t, a) =



g(a) exp
(
−
∫ a
a−t
g(s)ds
)
, if t < a,
g(a) exp
(
−
∫ a
0
g(s)ds
)
, if a < t.
Set
f(τ) := g(τ) exp
(
−
∫ τ
0
g(s)ds
)
, τ > 0.
One can check that f is a density function, supported on [τ , τ ], and f represents the density
of division of proliferating cells. In particularly,
∫ τ
τ
f(τ)dτ = 1.
Using the method of characteristics to determine p(t, a), we deduce, from (5)–(6), that
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the process of hematopoiesis is described by the following system:



dx
dt
= −
(
δ + β(x(t))
)
x(t)
+



2e−γt
∫ τ
τ
G(t, τ)Γ(τ − t)dτ, 0 ≤ t ≤ τ ,
2
∫ t
τ
e−γτf(τ)β(x(t − τ))x(t − τ)dτ
+2e−γt
∫ τ
t
G(t, τ)Γ(τ − t)dτ, τ ≤ t ≤ τ ,
2
∫ τ
τ
e−γτf(τ)β(x(t − τ))x(t − τ)dτ, τ ≤ t,
dy
dt
= −γy(t) + β(x(t))x(t)
−



e−γt
∫ τ
τ
G(t, τ)Γ(τ − t)dτ, 0 ≤ t ≤ τ,
∫ t
τ
e−γτf(τ)β(x(t − τ))x(t − τ)dτ
+e−γt
∫ τ
t
G(t, τ)Γ(τ − t)dτ, τ ≤ t ≤ τ ,
∫ τ
τ
e−γτf(τ)β(x(t − τ))x(t − τ)dτ, τ ≤ t.
(7)
One can give a direct biological explanation of system (7).
In the equation for the resting cells x(t), the first term in the right-hand side accounts
for G0-cell loss due to either the mortality and cellular differentiation (δ) or introduction in
the proliferating phase (β). The second term represents a cellular gain due to the movement
of proliferating cells one generation earlier. It requires some explanations. First, we recall
that all cells divide according to the density f , supported on [τ , τ ]. We shall call, in the
following, new proliferating cells, the resting cells introduced in the proliferating phase at the
considered time t. When t ≤ τ , no new proliferating cell is mature enough to divide, because
cells cannot divide before they have spent a time τ in the proliferating phase. Therefore, the
cellular gain can only proceed from cells initially in the proliferating phase. When t ∈ [τ , τ ],
the cellular increase is obtained by division of new proliferating cells and by division of the
initial population. Finally, when t ≥ τ , all initial proliferating cells have divided or died, and
the cellular gain is obtained by division of new proliferating cells introduced one generation
earlier. The factor 2 always accounts for the division of each cell into two daughter cells at
mitosis. The term e−γt, with t ∈ [0, τ ], describes the attenuation of the population, in the
proliferating phase, due to apoptosis.
In the equation for the proliferating cells y(t), the first term in the right-hand side accounts
for cellular loss by apoptosis and the second term is for cellular entry from the G0-phase.
The last term accounts for the flux of proliferating cells to the resting compartment.
We set µ :=
∫ ∞
0 ν(a)da. Then, initially, the populations in the two phases are given by
x(0) = µ and y(0) =
∫ τ
0
Γ(a)da.
At this point, one can make a remark. Since resting cells are introduced in the proliferating
phase with a rate β, then Γ(0), which represents the population of cells introduced at time
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t = 0 in the cycle, must satisfy
Γ(0) = β(µ)µ.
Taking into account the inevitable loss of proliferating cells by apoptosis and by division, we
suppose that Γ(a) is given by
Γ(a) =



e−γaβ(µ)µ, if a ∈ [0, τ),
e−γa exp
(
−
∫ a
τ
g(s)ds
)
β(µ)µ, if a ∈ [τ , τ).
(8)
This simply describes that Γ satisfies (4) (see Webb [35], page 8). With (8) and integrating
by parts, the initial conditions of system (7) become
x(0) = µ, y(0) = β(µ)µ
∫ τ
τ
f(τ)
(
1 − e−γτ
γ
)
dτ. (9)
When γ = 0, we have
y(0) = β(µ)µ
∫ τ
τ
τf(τ)dτ.
Assume that the function x 7→ xβ(x) is Lipschitz continuous. It is immediate to show
by steps that, for all µ ≥ 0, the system (7) under condition (9) has a unique nonnegative
continuous solution (x(t), y(t)) defined on [0,+∞).
One can notice that problem (7) reduces to a system of two delay differential equations,
with initial conditions solutions of a system of ordinary differential equations. On [0, τ ], the
first equation for x(t) in system (7) reduces to the ordinary differential equation



dϕ̃
dt
= −
(
δ + β(ϕ̃(t))
)
ϕ̃(t) + 2β(µ)µ
∫ τ
τ
e−γτf(τ)dτ, 0 ≤ t ≤ τ ,
ϕ̃(0) = µ,
(10)
and, on [τ , τ ], the second equation reduces to the following nonautonomous delay differential
equation



dϕ
dt
= −
(
δ + β(ϕ(t))
)
ϕ(t) + 2β(µ)µ
∫ τ
t
e−γτf(τ)dτ
+2
∫ t
τ
e−γτf(τ)β(ϕ(t − τ))ϕ(t − τ)dτ, t ∈ [τ, τ ],
ϕ(t) = ϕ̃(t), t ∈ [0, τ ],
(11)
where ϕ̃(t) is the unique solution of (10) for the initial condition µ.
By the same way, the solution y(t) of the second equation in (7), denoted by ψ(t), is given
in terms of the unique solution ϕ̃(t) of (10), associated with µ, and the unique solution ϕ(t)
of (11), for t ∈ [0, τ ].
Then, the system (7) can be written as an autonomous system of delay differential equa-
tions, for t ≥ τ ,
dx
dt
= −
(
δ + β(x(t))
)
x(t) + 2
∫ τ
τ
e−γτf(τ)β(x(t − τ))x(t − τ)dτ, (12a)
dy
dt
= −γy(t) + β(x(t))x(t) −
∫ τ
τ
e−γτf(τ)β(x(t − τ))x(t − τ)dτ, (12b)
6
M. Adimy, F. Crauste and S. Ruan Hematopoiesis Model
with, for t ∈ [0, τ ],
x(t) = ϕ(t), y(t) = ψ(t). (13)
The solutions of (12b) are given explicitly by
y(t) =
∫ τ
τ
f(τ)
( ∫ t
t−τ
e−γ(t−s)β(x(s))x(s) ds
)
dτ for t ≥ τ . (14)
One can notice that y(t) does not depend anymore on the initial population Γ(a) after
one generation, that is when t ≥ τ . This can be explained as follows: Cells initially in
the proliferating phase have divided or died after one generation; hence, new cells in the
proliferating phase can only come from resting cells x(t).
On the other hand, one may have already noticed that the solutions of (12a) do not
depend on the solutions of (12b) whereas the converse is not true. The expression of y(t) in
(14) gives more precise information on the influence of the behavior of x(t) on the stability
of the solutions y(t). These results are proved in the following lemma.
Lemma 2.1. Let (x(t), y(t)) be a solution of (12). If limt→+∞ x(t) exists and equals C ≥ 0,
then
lim
t→+∞
y(t) =



β(C)C
∫ τ
τ
f(τ)
(
1 − e−γτ
γ
)
dτ, if γ > 0,
β(C)C
∫ τ
τ
τf(τ)dτ, if γ = 0.
(15)
If x(t) is P -periodic, then y(t) is also P -periodic.
Proof. By using (14), we obtain that
y(t) =
∫ τ
τ
f(τ)
( ∫ τ
0
e−γsβ(x(t − s))x(t − s) ds
)
dτ for t ≥ τ . (16)
Hence,
lim
t→+∞
y(t) = β(C)C
∫ τ
τ
f(τ)
( ∫ τ
0
e−γs ds
)
dτ,
and (15) follows immediately.
When x(t) is P -periodic, then using (16) it is obvious to see that y(t) is also periodic with
the same period.
Lemma 2.1 shows the influence of (12a) on the stability of the entire system, since the
stability of solutions of (12a) leads to stability of the solutions of (12b).
Before studying the stability of (12a), we prove a boundedness result for the solutions
of this equation. The proof is based on the one given by Mackey and Rudnicki [22] for a
differential equation with a discrete delay.
Proposition 2.1. Assume that δ > 0. Then the solutions of (12a) are bounded.
Proof. Assume that δ > 0 and 2(
∫ τ
τ
e−γτf(τ)dτ)β(0) ≥ δ. Since β is decreasing and
limx→+∞ β(x) = 0, there exists a unique x0 ≥ 0 such that
2
(∫ τ
τ
e−γτf(τ)dτ
)
β(x0) = δ
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and
2
( ∫ τ
τ
e−γτf(τ)dτ
)
β(x) ≤ δ for x ≥ x0. (17)
If 2(
∫ τ
τ
e−γτf(τ)dτ)β(0) < δ, then (17) holds with x0 = 0. Set
x1 := 2
( ∫ τ
τ
e−γτf(τ)dτ
)
β(0)x0
δ
≥ 0.
One can check that
2
(∫ τ
τ
e−γτf(τ)dτ
)
max
0≤y≤x
(
β(y)y
)
≤ δx for x ≥ x1. (18)
Indeed, let y ∈ [0, x). If y ≤ x0, then
2
( ∫ τ
τ
e−γτf(τ)dτ
)
β(y)y ≤ 2
( ∫ τ
τ
e−γτf(τ)dτ
)
β(0)x0 = δx1 ≤ δx
and, if y > x0, then
2
( ∫ τ
τ
e−γτf(τ)dτ
)
β(y)y ≤ δy ≤ δx.
Hence, (18) holds.
Assume, by contradiction, that lim supt→+∞ x(t) = +∞, where x(t) is a solution of (12a).
Then, there exists t0 > τ such that
x(t) ≤ x(t0) for t ∈ [t0 − τ , t0] and x(t0) > x1.
With (18), we obtain that
2
∫ τ
τ
e−γτf(τ)β(x(t0 − τ))x(t0 − τ)dτ ≤ δx(t0).
This yields, with (12a), that
dx
dt
(t0) ≤ −β(x(t0))
)
x(t0) < 0,
which gives a contradiction. Hence, lim supt→+∞ x(t) < +∞.
When δ = 0, the solutions of (12a) may not be bounded. We show, in the next proposition,
that these solutions may explode under some conditions. However, one can notice, using (16),
that the solutions of (12b) may still be stable in this case.
Proposition 2.2. Assume that δ = 0 and
∫ τ
τ
e−γτf(τ)dτ >
1
2
. (19)
In addition, assume that there exists x ≥ 0 such that the function x 7→ xβ(x) is decreasing
for x ≥ x. If µ ≥ x, then the unique solution x(t) of (12a) satisfies
lim
t→+∞
x(t) = +∞.
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Proof. One can notice that, if limt→+∞ x(t) = C exists, then (12a) leads to
(
2
∫ τ
τ
e−γτf(τ)dτ − 1
)
β(C)C = 0.
It follows that C = 0.
Let µ ≥ x be given. Consider the equation
ϕ̃′(t) = 2β(µ)µ
∫ τ
τ
e−γτf(τ)dτ − β(ϕ̃(t))ϕ̃(t) for 0 ≤ t ≤ τ (20)
with ϕ̃(0) = µ. Since the function x 7→ xβ(x) is decreasing for x ≥ x, it is immediate that
every solution ϕ̃(t) of (20) satisfies, for t ∈ [0, τ ],
ϕ̃′(t) ≥
(
2
∫ τ
τ
e−γτf(τ)dτ − 1
)
β(µ)µ > 0.
Consider now the problem



ϕ′(t) = −β(ϕ(t))ϕ(t) + 2β(µ)µ
∫ τ
t
e−γτf(τ)dτ
+2
∫ t
τ
e−γτf(τ)β(ϕ(t − τ))ϕ(t − τ)dτ, t ∈ [τ , τ ],
ϕ(t) = ϕ̃(t), t ∈ [0, τ ],
(21)
where ϕ̃(t) is the unique solution of (20) for the initial condition µ. Then,
ϕ′(τ ) ≥
(
2
∫ τ
τ
e−γτf(τ)dτ − 1
)
β(µ)µ > 0.
So, there exists ε > 0 such that τ + ε ≤ τ and ϕ′(t) > 0 for t ∈ [τ , τ + ε). Since µ ≤ ϕ(τ ) ≤
ϕ(τ) ≤ ϕ(τ + ε), for τ ∈ [τ , τ + ε], we have
ϕ′(τ + ε) ≥
(
2
∫ τ
τ+ε
e−γτf(τ)dτ − 1
)
β(ϕ(τ + ε))ϕ(τ + ε)
+2
(∫ τ+ε
τ
e−γτf(τ)dτ
)
β(ϕ(τ + ε))ϕ(τ + ε)
≥
(
2
∫ τ
τ
e−γτf(τ)dτ − 1
)
β(ϕ(τ + ε))ϕ(τ + ε).
Condition (19) leads to ϕ′(τ + ε) > 0. Using a similar argument, we obtain that
ϕ′(t) > 0 for t ∈ [τ, τ ].
To conclude, consider the delay differential equation
x′(t) = 2
∫ τ
τ
e−γτf(τ)β(x(t − τ))x(t − τ)dτ − β(x(t))x(t) (22)
with an initial condition given on [τ , τ ] by the solution ϕ(t) of (21). Using the same reasoning
as in the previous cases, we obtain that
x′(τ ) > 0.
9
M. Adimy, F. Crauste and S. Ruan Hematopoiesis Model
We thus deduce that
x′(t) > 0 for t ≥ 0.
This completes the proof.
The assumption on the function x 7→ xβ(x) in Proposition 2.2 is satisfied for example
when β is given by (1), with n > 1. In this case, we can take x = θ/(n− 1)1/n.
We now turn our attention to the stability of (12). Problem (12) has at most two equi-
libria. The first one, E0 = (0, 0), always exists: it corresponds to the extinction of the
population. The second one describes the expected equilibrium of the population; it is a
nontrivial equilibrium E∗ = (x∗, y∗), where x∗ is the unique solution of
(
2
∫ τ
τ
e−γτf(τ)dτ − 1
)
β(x∗) = δ (23)
and, from (7) and (9),
y∗ =



β(x∗)x∗
∫ τ
τ
f(τ)
(
1 − e−γτ
γ
)
dτ, if γ > 0,
δx∗
∫ τ
τ
τf(τ)dτ, if γ = 0.
(24)
Since β is a positive decreasing function and limx→+∞ β(x) = 0, then the equilibrium E
∗
exists if and only if
0 < δ <
(
2
∫ τ
τ
e−γτf(τ)dτ − 1
)
β(0). (25)
We shall study in Section 3 the stability of the two equilibria E0 and E
∗. From Lemma
2.1, we only need to focus on the behavior of the equilibria of (12a), that is x ≡ 0 and x ≡ x∗,
to obtain information on the behavior of the entire population.
3 Asymptotic stability
We first show that E0 is globally asymptotically stable when it is the only equilibrium, and
that it becomes unstable when the nontrivial equilibrium E∗ appears: a transcritical bifur-
cation occurs then. In a second part, we determine conditions for the nontrivial equilibrium
E∗ to be asymptotically stable.
3.1 Stability of the trivial equilibrium
In the next theorem, we give a necessary and sufficient condition for the trivial equilibrium of
(12a) to be globally asymptotically stable using a Lyapunov functional. Concerning definition
and interest of Lyapunov functionals for delay differential equations, we refer to Hale [13].
Theorem 3.1. The trivial equilibrium of the system (12) is globally asymptotically stable if
(
2
∫ τ
τ
e−γτf(τ)dτ − 1
)
β(0) < δ (26)
and unstable if
δ <
(
2
∫ τ
τ
e−γτf(τ)dτ − 1
)
β(0). (27)
10
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Proof. We first assume that (26) holds. Denote by C+ the set of continuous nonnegative
functions on [0, τ ] and define the mapping J : C+ → [0,+∞) by
J(ϕ) = B(ϕ(τ )) +
∫ τ
τ
e−γτf(τ)
( ∫ τ
τ−τ
(
β
(
ϕ(θ)
)
ϕ(θ)
)2
dθ
)
dτ
for all ϕ ∈ C+, where
B(x) =
∫ x
0
β(s)s ds for all x ≥ 0.
We set (see [13])
J̇(ϕ) = lim sup
t→0+
J(xϕt ) − J(ϕ)
t
for ϕ ∈ C+,
where xϕ is the unique solution of (12a) associated with the initial condition ϕ ∈ C+, and
xϕt (θ) = x
ϕ(t+ θ) for θ ∈ [0, τ ]. Then,
J̇(ϕ) =
dϕ
dt
(τ )β
(
ϕ(τ )
)
ϕ(τ )
+
∫ τ
τ
e−γτf(τ)
((
β
(
ϕ(τ )
)
ϕ(τ )
)2
−
(
β
(
ϕ(τ − τ)
)
ϕ(τ − τ)
)2)
dτ.
(28)
Using (12a), we have
dϕ
dt
(τ ) = −
(
δ + β
(
ϕ(τ )
))
ϕ(τ ) + 2
∫ τ
τ
e−γτf(τ)β
(
ϕ(τ − τ)
)
ϕ(τ − τ)dτ.
Therefore, (28) becomes
J̇(ϕ) = −
(
δ + β
(
ϕ(τ )
))
β
(
ϕ(τ )
)
ϕ2(τ ) +
∫ τ
τ
e−γτf(τ)
[(
β
(
ϕ(τ )
)
ϕ(τ )
)2
+2β
(
ϕ(τ )
)
ϕ(τ )β
(
ϕ(τ − τ)
)
ϕ(τ − τ) −
(
β
(
ϕ(τ − τ)
)
ϕ(τ − τ)
)2]
dτ
= −
(
δ + β
(
ϕ(τ )
))
β
(
ϕ(τ )
)
ϕ2(τ ) + 2
(
β
(
ϕ(τ )
)
ϕ(τ )
)2 ∫ τ
τ
e−γτf(τ)dτ
−
∫ τ
τ
e−γτf(τ)
[
β
(
ϕ(τ )
)
ϕ(τ ) − β
(
ϕ(τ − τ)
)
ϕ(τ − τ)
]2
dτ.
Hence,
J̇(ϕ) ≤ −u(ϕ(τ)),
where the function u is defined, for x ≥ 0, by
u(x) = r(x)β(x)x2 (29)
with
r(x) = δ −
(
2
∫ τ
τ
e−γτf(τ)dτ − 1
)
β(x).
Since β is decreasing, r is a monotone function. Moreover, (26) leads to r(0) > 0, and
limx→∞ r(x) = δ ≥ 0. Therefore, r is positive on [0,+∞).
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Consequently, the function u defined by (29) is nonnegative on [0,+∞) and u(x) = 0 if
and only if x = 0. We deduce that every solution of (12a), with ϕ ∈ C+, tends to zero as t
tends to +∞.
We suppose now that (27) holds. The linearization of (12a) around x ≡ 0 leads to the
characteristic equation
∆0(λ) := λ+ δ + β(0) − 2β(0)
∫ τ
τ
e−(λ+γ)τf(τ)dτ = 0. (30)
We consider ∆0 as a real function. Since
d∆0
dλ
= 1 + 2β(0)
∫ τ
τ
τe−(λ+γ)τf(τ)dτ > 0,
it follows that ∆0 is an increasing function. Moreover, (30) yields
lim
λ→−∞
∆0(λ) = −∞, lim
λ→+∞
∆0(λ) = +∞,
and (27) implies that
∆0(0) = δ −
(
2
∫ τ
τ
e−γτf(τ)dτ − 1
)
β(0) < 0.
Hence, ∆0(λ) has a unique real root which is positive. Consequently, (30) has at least one
characteristic root with positive real part. Therefore, the equilibrium x ≡ 0 of (12a) is not
stable. This completes the proof.
The inequality (26) is satisfied when δ or γ (the mortality rates) is large or when β(0)
is small. Biologically, these conditions correspond to a population which cannot survive,
because the mortality rates are too large or, simply, because not enough cells are introduced
in the proliferating phase and, then, the population renewal is not supplied.
Remark 1. One can notice that when
∫ τ
τ
e−γτf(τ)dτ <
1
2
,
the trivial equilibrium E0 is the only equilibrium of (12) and is globally asymptotically stable.
When ∫ τ
τ
e−γτf(τ)dτ =
1
2
,
then E0 is globally asymptotically stable if δ > 0. When the equality
(
2
∫ τ
τ
e−γτf(τ)dτ − 1
)
β(0) = δ
holds, one can check that λ = 0 is a characteristic root of (30) and all other characteristic
roots have negative real parts. Hence, we cannot conclude on the stability or instability of
the trivial equilibrium E0 of (12) without further analysis. However, this is not the subject
of this paper.
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3.2 Stability of the nontrivial equilibrium
We concentrate, in this section, on the equilibrium E∗ = (x∗, y∗) defined by (23)–(24). Hence,
throughout this section, we assume that (25) holds, that is
0 < δ <
(
2
∫ τ
τ
e−γτf(τ)dτ − 1
)
β(0).
Since δ > 0 and β(0) > 0, (25) implies, in particularly, that
∫ τ
τ
e−γτf(τ)dτ >
1
2
. (31)
From Lemma 2.1, we only need to focus on the stability of the nontrivial equilibrium x ≡ x∗
of (12a). To that aim, we linearize (12a) around x∗. Denote by β∗ ∈ R the quantity
β∗ :=
d
dx
(
xβ(x)
)∣∣∣
x=x∗
= β(x∗) + x∗β′(x∗) (32)
and set u(t) = x(t) − x∗. The linearization of (12a) is given by
du
dt
= −(δ + β∗)u(t) + 2β∗
∫ τ
τ
e−γτf(τ)u(t− τ)dτ.
Then, the characteristic equation is
∆(λ) := λ+ δ + β∗ − 2β∗
∫ τ
τ
e−(λ+γ)τf(τ)dτ = 0. (33)
One can notice that the function x 7→ xβ(x) is usually not monotone. For example, if β
is given by (1) with n > 1, the function x 7→ xβ(x) is increasing for x ≤ θ/(n − 1)1/n and
decreasing for x > θ/(n− 1)1/n. In this case, β∗ is nonnegative when x∗ is close to zero and
negative when x∗ is large enough.
The following theorem deals with the asymptotic stability of E∗.
Theorem 3.2. Assume that (25) holds. If
β∗ ≥ −
δ
2
∫ τ
τ
e−γτf(τ)dτ + 1
, (34)
then E∗ is locally asymptotically stable.
Proof. We first prove that the equilibrium x ≡ x∗ is locally asymptotically stable when
β∗ ≥ 0. We consider the mapping ∆(λ), given by (33), as a real function of λ. Then ∆(λ) is
continuously differentiable on R and its first derivative is given by
d∆
dλ
= 1 + 2β∗
∫ τ
τ
τe−(λ+γ)τf(τ)dτ > 0. (35)
Hence, ∆(λ) is an increasing function of λ satisfying
lim
λ→−∞
∆(λ) = −∞ and lim
λ→+∞
∆(λ) = +∞.
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Then, there exists a unique λ0 ∈ R such that ∆(λ0) = 0. Moreover, since
∆(0) = δ −
(
2
∫ τ
τ
e−γτf(τ)dτ − 1
)
β∗,
we deduce, by using (23), (31) and (32), that
∆(0) = −
(
2
∫ τ
τ
e−γτf(τ)dτ − 1
)
x∗β′(x∗) > 0.
Consequently, λ0 < 0.
Let λ = µ + iω be a characteristic root of (33) such that µ > λ0. Considering the real
part of (33), we obtain that
µ = −(δ + β∗) + 2β∗
∫ τ
τ
e−(µ+γ)τf(τ) cos(ωτ)dτ. (36)
Using (33), with λ = λ0, together with (36), we then obtain
µ− λ0 = 2β
∗
∫ τ
τ
e−γτf(τ)
[
e−µτ cos(ωτ) − e−λ0τ
]
dτ.
However,
e−µτ cos(ωτ) − e−λ0τ < 0
for all τ ∈ [τ , τ ]. So we obtain that µ− λ0 < 0, which leads to a contradiction. This implies
that all characteristic roots of (33) have negative real part and the equilibrium x ≡ x∗ of
(12a) is locally asymptotically stable.
Now, assume that β∗ < 0 and
β∗ > −
δ
2
∫ τ
τ
e−γτf(τ)dτ + 1
. (37)
Let λ = µ+ iω be a characteristic root of (33) such that µ > 0. Since
∫ τ
τ
e−γτf(τ)
(
e−µτ cos(ωτ) + 1
)
dτ ≥ 0,
we have
2β∗
∫ τ
τ
e−(µ+γ)τf(τ) cos(ωτ)dτ ≤ −2β∗
∫ τ
τ
e−γτf(τ)dτ.
So, (36) and (37) lead to
µ ≤ −(δ + β∗) − 2β∗
∫ τ
τ
e−γτf(τ)dτ < 0,
a contradiction. Therefore, µ ≤ 0.
Suppose now that (33) has a purely imaginary characteristic root iω, with ω ∈ R. Then,
(36) leads to ∫ τ
τ
e−γτf(τ) cos(ωτ)dτ =
δ + β∗
2β∗
.
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However, ∣∣∣∣
∫ τ
τ
e−γτf(τ) cos(ωτ)dτ
∣∣∣∣ ≤
∫ τ
τ
e−γτf(τ)dτ
and (37) yields
δ + β∗
2β∗
< −
∫ τ
τ
e−γτf(τ)dτ.
Hence, (33) has no purely imaginary root. Consequently, all characteristic roots of (33) have
negative real part and the nontrivial equilibrium x ≡ x∗ of (12a) is locally asymptotically
stable.
Finally, assume that
β∗ = −
δ
2
∫ τ
τ
e−γτf(τ)dτ + 1
. (38)
Consider a characteristic root λ = µ+ iω of (33), which reduces, with (38), to
λ− 2β∗
∫ τ
τ
e−γτf(τ)
(
1 + e−λτ
)
dτ = 0. (39)
Suppose, by contradiction, that µ > 0. By considering the real part of (39), we have
µ = 2β∗
∫ τ
τ
e−γτf(τ)
(
1 + e−µτ cos(ωτ)
)
dτ < 0.
We obtain a contradiction, therefore µ ≤ 0. If we suppose now that µ = 0 then we easily
obtain that
cos(ωτ) = −1 for all τ ∈ [τ, τ ],
which is impossible. It follows that all characteristic roots of (33) have negative real parts
when (38) holds and the equilibrium x ≡ x∗ is locally asymptotically stable.
From Lemma 2.1, we conclude that E∗ is locally asymptotically stable when (34) holds.
The asymptotic stability of E∗ is shown in Fig. 1. Values of the parameters are given by
(2), except n = 2.42, τ = 0 and τ = 7 days. The function f is defined by
f(τ) =



1
τ − τ
, if τ ∈ [τ, τ ],
0, otherwise.
(40)
The Matlab solver for delay differential equations, dde23 [32], is used to obtain Fig. 1,
as well as illustrations in Section 4 and Section 5.
When (34) does not hold, we have necessarily β∗ < 0. In this case, we cannot obtain the
stability of E∗ for all values of β∗. In fact, in the next section we are going to show that the
equilibrium E∗ can be destabilized, in this case, via a Hopf bifurcation.
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Figure 1: The solutions x(t) (solid curve) and y(t) (dashed curve) of system (12) are drawn
for values of the parameters β0, δ and γ given by (2), n = 2.42, τ = 0 and τ = 7 days.
In this case, the nontrivial equilibrium E∗ is locally asymptotically stable, even though the
solutions oscillate transiently.
4 Hopf bifurcation and periodic solutions
In this section, we show that the equilibrium x ≡ x∗ of (12a) can become unstable when (34)
does not hold anymore. Throughout this section, we assume that
τ = 0
and (25) holds, that is
0 < δ <
(
2
∫ τ
0
e−γτf(τ)dτ − 1
)
β(0).
From Proposition 2.1, the solutions of (12a) are bounded. Consequently, instability in (12a)
occurs only via oscillatory solutions.
We assume that
β∗ < −
δ
2
∫ τ
0
e−γτf(τ)dτ + 1
:= δ̃. (41)
Otherwise, the nontrivial equilibrium x ≡ x∗ of (12a) is locally asymptotically stable (see
Theorem 3.2).
If instability occurs for a particular value β∗ < δ̃, a characteristic root of (33) must
intersect the imaginary axis. Hence, we look for purely imaginary characteristic roots iω,
ω ∈ R, of (33). If iω is a characteristic root of (33), then ω is a solution of the system
{
δ + β∗(1 − 2C(ω)) = 0,
ω + 2β∗S(ω) = 0,
(42)
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where
C(ω) :=
∫ τ
0
e−γτf(τ) cos(ωτ)dτ and S(ω) :=
∫ τ
0
e−γτf(τ) sin(ωτ)dτ.
One can notice that ω = 0 is not a solution of (42). Otherwise,
δ =
(
2
∫ τ
0
e−γτf(τ)dτ − 1
)
β∗ < 0,
which gives a contradiction. Moreover, if ω is a solution of (42), then −iω is also a charac-
teristic root. Thus, we only look for positive solutions ω.
Lemma 4.1. Assume that the function τ 7→ e−γτf(τ) is decreasing. Then, for each δ such
that (25) is satisfied, (42) has at least one solution (β∗c , ωc), with β
∗
c < δ̃ and ωc > 0. It
follows that (33) has at least one pair of purely imaginary roots ±iωc for β
∗ = β∗c . Moreover,
±iωc are simple characteristic roots of (33). Consider the branch of characteristic roots
λ(−β∗), such that λ(−β∗c ) = iωc. Then
dRe(λ)
d(−β∗)
∣∣∣∣
β∗=β∗
c
> 0 if and only if − δ
(
S(ωc)
ωc
)′
> C′(ωc). (43)
Proof. First, we show by induction that S(ω) > 0 for ω > 0. It is clear that S(ω) > 0 if
ωτ ∈ (0, π]. Suppose that ωτ ∈ (π, 2π]. Then
S(ω) =
1
ω
∫ ωτ
0
e−γ
τ
ω f
( τ
ω
)
sin(τ)dτ
=
1
ω
∫ π
0
e−γ
τ
ω f
( τ
ω
)
sin(τ)dτ +
1
ω
∫ ωτ
π
e−γ
τ
ω f
( τ
ω
)
sin(τ)dτ.
Since f is supported on the interval [0, τ ], it follows that
∫ 2π
ωτ
e−γ
τ
ω f
( τ
ω
)
sin(τ)dτ = 0.
So, we obtain
S(ω) =
1
ω
∫ π
0
e−γ
τ
ω f
( τ
ω
)
sin(τ)dτ +
1
ω
∫ 2π
π
e−γ
τ
ω f
( τ
ω
)
sin(τ)dτ
=
1
ω
∫ π
0
(
e−γ
τ
ω f
( τ
ω
)
− e−γ
τ+π
ω f
(τ + π
ω
))
sin(τ)dτ.
Since the function τ 7→ e−γτf(τ) is decreasing, we finally get S(ω) > 0. Using a similar
argument for ωτ ∈ (kπ, (k + 1)π], with k ∈ N, k ≥ 2, we deduce that S(ω) > 0 for all ω > 0.
Consider the equation
g(ω) :=
ω
(
1 − 2C(ω)
)
2S(ω)
= δ, ω > 0. (44)
The function g is continuous with
lim
ω→0
g(ω) =
1 − 2C(0)
2
∫ τ
0
τe−γτf(τ)dτ
< 0 (45)
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because (25) leads to 1− 2C(0) < 0. Moreover, the Riemann–Lebesgue’s lemma implies that
lim
ω→+∞
C(ω) = lim
ω→+∞
S(ω) = 0.
This yields
lim
ω→+∞
g(ω) = +∞.
We conclude that there exists a solution ωc > 0 of (44). Since S(ωc) > 0 and g(ωc) = δ > 0,
we obtain 1 − 2C(ωc) > 0. Set
β∗c = −
δ
1 − 2C(ωc)
< 0. (46)
Since |C(ωc)| < C(0), it follows that
β∗c < −
δ
2C(0) + 1
= δ̃.
One can check that (β∗c , ωc) is a solution of (42). It follows that ±iωc are characteristic roots
of (33) for β∗ = β∗c .
Define a branch of characteristic roots λ(−β∗) of (33) such that λ(−β∗c ) = iωc. We use
the parameter −β∗ because β∗ < δ̃ < 0.
Using (33), we obtain
[
1 + 2β∗
∫ τ
0
τe−(λ+γ)τf(τ)dτ
]
dλ
d(−β∗)
= 1 − 2
∫ τ
0
e−(λ+γ)τf(τ)dτ. (47)
If we assume, by contradiction, that iωc is not a simple root of (33), then (47) leads to
C(ωc) =
1
2
and S(ωc) = 0.
Since S(ωc) > 0, we obtain a contradiction. Thus, iωc is a simple root of (33).
Moreover, using (47), we have
(
dλ
d(−β∗)
)−1
=
1 + 2β∗
∫ τ
0
τe−(λ+γ)τf(τ)dτ
1 − 2
∫ τ
0
e−(λ+γ)τf(τ)dτ
.
Since λ is a characteristic root of (33), we also have
1 − 2
∫ τ
0
e−(λ+γ)τf(τ)dτ = −
λ+ δ
β∗
.
So, we deduce
(
dλ
d(−β∗)
)−1
= −β∗
1 + 2β∗
∫ τ
0
τe−(λ+γ)τf(τ)dτ
λ+ δ
.
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Then,
sign
{
dRe(λ)
d(−β∗)
}∣∣∣∣
β∗=β∗
c
= sign
{
Re
(
dλ
d(−β∗)
)−1}∣∣∣∣
β∗=β∗
c
= sign
{
Re
(
− β∗
1 + 2β∗
∫ τ
0
τe−(λ+γ)τf(τ)dτ
λ+ δ
)}∣∣∣∣
β∗=β∗
c
= sign
{
− β∗c
δ(1 + 2β∗cS
′(ωc)) + 2β
∗
cωcC
′(ωc)
δ2 + ω2c
}
= sign
{
δ(1 + 2β∗cS
′(ωc)) + 2β
∗
cωcC
′(ωc)
}
.
From (46) and the fact that 1 − 2C(ωc) > 0, this leads to
sign
{
dRe(λ)
d(−β∗)
}∣∣∣∣
β∗=β∗
c
= sign
{
1 − 2C(ωc) − 2δS
′(ωc) − 2ωcC
′(ωc)
}
= sign
{
2ωc
(
− C′(ωc) − δ
(
S(ωc)
ωc
)′)}
= sign
{
− C′(ωc) − δ
(
S(ωc)
ωc
)′}
.
This concludes the proof.
Remark 2. Consider the function g defined by (44) and denote by α the quantity
α :=
(
2
∫ τ
0
e−γτf(τ)dτ − 1
)
β(0).
Define the sets
Ω := {ω > 0; 0 < g(ω) < α and g′(ω) = 0} and Λ := g(Ω).
One can notice that Λ is finite (or empty). If δ ∈ (0, α) \ Λ, then
dRe(λ)
d(−β∗)
∣∣∣∣
β∗=β∗
c
6= 0.
Indeed, we have
g′(ω) = −
ω
S(ω)
(
g(ω)
(
S(ω)
ω
)′
+ C′(ω)
)
, ω > 0.
Since δ /∈ Λ, we have g′(ωc) 6= 0. Moreover, g(ωc) = δ. Thus
C′(ωc) 6= −δ
(
S(ωc)
ωc
)′
.
We conclude by using (43).
Lemma 4.1, together with Remark 2, allows us to state and prove the following theorem.
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Theorem 4.1. Assume that the function τ 7→ e−γτf(τ) is decreasing. Then, for each δ /∈ Λ
satisfying (25), there exists β∗c < δ̃ such that the equilibrium x ≡ x
∗ is locally asymptotically
stable when β∗c < β
∗ ≤ δ̃ and a Hopf bifurcation occurs at x ≡ x∗ when β∗ = β∗c .
Proof. First, recall that x ≡ x∗ is locally asymptotically stable when β∗ = δ̃ (see Theorem
3.2). We recall that, from the properties of the function g, equation (44) has a finite number
of solutions (see Lemma 4.1). We set
β∗c = −
δ
1 − 2C(ω∗c )
,
where ω∗c is the smaller positive real such that
C(ω∗c ) = min{C(ω); ω is a solution of (44)}.
Then, β∗c is the maximum value of β
∗ (as defined in Lemma 4.1) which gives a solution of
(42). From Lemma 4.1, (33) has no purely imaginary roots while β∗c < β
∗ ≤ δ̃. Consequently,
Rouché’s Theorem [10, p.248] leads to the local asymptotic stability of x ≡ x∗.
When β∗ = β∗c , (33) has a pair of purely imaginary roots ±iωc, ωc > 0 (see Lemma 4.1).
Moreover, since δ /∈ Λ, Remark 2 implies that
dRe(λ)
d(−β∗)
∣∣∣∣
β∗=β∗
c
6= 0.
Assume, by contradiction, that
dRe(λ)
d(−β∗)
< 0
for β∗ > β∗c , β
∗ close to β∗c . Then there exists a characteristic root λ(−β
∗) such that
Reλ(−β∗) > 0. This contradicts the fact that x ≡ x∗ is locally asymptotically stable when
β∗ > β∗c . Thus, we obtain
dRe(λ)
d(−β∗)
∣∣∣∣
β∗=β∗
c
> 0.
This implies the existence of a Hopf bifurcation at x ≡ x∗ for β∗ = β∗c .
With the values of δ, γ and β0 given by (2), and τ = 7 days, (12) has periodic solutions
for β∗c = −0.3881 with a period about 33 days. This value of β
∗
c corresponds to n = 2.53 (see
Fig. 2 and 3). The function f is given by (40).
The bifurcation parameter was chosen to be β∗ in this study, and the values of β∗ depend
strongly on the sensitivity n of the function β(x), since all other parameters are fixed by (25).
In this model, the sensitivity n plays a crucial role in the appearance of periodic solutions.
Pujo-Menjouet and Mackey [27] already noticed the influence of this parameter on system
(12) when the delay is constant (or equivalently, when f is a Dirac measure). The sensitivity
n describes the way the rate of introduction in the proliferating phase reacts to changes in
the resting phase population produced by external stimuli: a release of erythropoietin, for
example, or the action of some growth factors.
Of course, the influence of other parameters (like mortality rates δ and γ, or the minimum
and maximum delays τ and τ ) on the appearance of periodic solutions could be studied.
However, since periodic hematological diseases — defined and described in Section 5 —
are supposed to be due to hormonal control destabilization (see [11]), then the parameter
n, among other parameters, seems to be appropriate to identify causes leading to periodic
solutions in (12).
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Figure 2: The solutions of system (12), x(t) (solid curve) and y(t) (dashed curve), are drawn
when the Hopf bifurcation occurs. This corresponds to n = 2.53 with the other parameters
given by (2) and τ = 7 days. Periodic solutions appear with period of the oscillations about
33 days.
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Figure 3: For the values used in Fig.2, the solutions are shown in the (x, y)-plane: the
trajectories reach a limit cycle, surrounding the equilibrium.
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5 Discussion
Among the wide range of diseases affecting blood cells, periodic hematological diseases (Hau-
rie et al. [14]) are of main importance because of their intrinsic nature. These diseases are
characterized by significant oscillations in the number of circulating cells, with periods rang-
ing from weeks (19–21 days for cyclical neutropenia [14]) to months (30 to 100 days for chronic
myelogenous leukemia [14]) and amplitudes varying from normal to low levels or normal to
high levels, depending on the cells types [14]. Because of their dynamic character, periodic
hematological diseases offer an opportunity to understand some of the regulating processes
involved in the production of hematopoietic cells, which are still not well-understood.
Some periodic hematological diseases involve only one type of blood cells, for example,
red blood cells in periodic auto-immune hemolytic anemia (Bélair et al. [4]) or platelets in
cyclical thrombocytopenia (Santillan et al. [31]). In these cases, periods of the oscillations
are usually between two and four times the bone marrow production delay. However, other
periodic hematological diseases, such as cyclical neutropenia (Haurie et al. [14]) or chronic
myelogenous leukemia (Fortin and Mackey [11]), show oscillations in all of the circulating
blood cells, i.e., white cells, red blood cells and platelets. These diseases involve oscillations
with quite long periods (on the order of weeks to months). A destabilization of the pluripo-
tential stem cell population (from which all of the mature blood cells types are derived) seems
to be at the origin of these diseases.
We focus, in particularly, on chronic myelogenous leukemia (CML), a cancer of the white
cells, resulting from the malignant transformation of a single pluripotential stem cell in the
bone marrow (Pujo-Menjouet et al. [26]). As described in Morley et al. [24], oscillations can
be observed in patients with CML, with the same period for white cells, red blood cells and
platelets. This is called periodic chronic myelogenous leukemia (PCML). The period of the
oscillations in PCML ranges from 30 to 100 days (Haurie et al. [14], Fortin and Mackey [11]),
depending on patients. The difference between these periods and the average pluripotential
cell cycle duration (between 1 to 4 days, as observed in mouses, see Mackey [18]) is still not
well-understood.
Recently, to understand the dynamics of periodic chronic myelogenous leukemia, Pujo-
Menjouet et al. [26] considered a model for the regulation of stem cell dynamics and investi-
gated the influence of parameters in this stem cell model on the oscillations period when the
model becomes unstable and starts to oscillate. In this paper, taking into account the fact
that a cell cycle has two phases, that is, stem cells in process are either in a resting phase or
actively proliferating, and assuming that cells divide at different ages, we proposed a system
of differential equations with distributed delay to model the dynamics of hematopoietic stem
cells. By constructing a Lyapunov functional, we gave conditions for the trivial equilibrium
to be globally asymptotically stable. Local stability and Hopf bifurcation of the nontrivial
equilibrium were studied, the existence of a Hopf bifurcation leading to the appearance of
periodic solutions in this model, with a period around 30 days at the bifurcation.
Numerical simulations show that periodic solutions occur after the bifurcation, with peri-
ods increasing as the bifurcation parameter (the sensitivity n) increases. In Fig. 4, solutions
oscillate around the equilibrium values with periods around 45 days. Moreover, amplitudes
of the oscillations range from low values to normal values. The sensitivity is equal to n = 3,
that is the parameters are given by (2). This corresponds to values given by Mackey [16],
values for which abnormal behavior (periodic) is usually observed in all circulating blood
cells types.
When n continues to increase, longer oscillations periods are observed with amplitudes
varying from low values to high values (see Fig. 5). This situation characterizes periodic
chronic myelogenous leukemia, with periods in the order of two months (70 days).
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Figure 4: Solutions x(t) (solid curve) and y(t) (dashed curve) of system (12) oscillate with
periods close to 45 days; the parameters are the same as in Fig 2, with n = 3. The amplitudes
of the oscillations range from low values to normal values.
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Figure 5: Solutions x(t) (solid curve) and y(t) (dashed curve) of system (12) oscillate with
periods close to 70 days; the parameters are the same as in Fig 2, with n = 4. The amplitudes
of the oscillations range from low values to high values.
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Moreover, the oscillations observed in Fig. 4 and 5 look very much like relaxation oscilla-
tions. Experimental data from patients with PCML suggest that the shape of oscillations is
of a relaxation oscillator type [11, 14]. Furthermore, Fowler and Mackey [12] showed that a
model for hematopoiesis with a discrete delay may also exhibit relaxation oscillations. There-
fore, it seems that not only periods and amplitudes of the oscillations correspond to the ones
observed in PCML, but also the shape of the oscillations.
Numerical simulations demonstrated that long period oscillations in the circulating cells
are possible in our model even with short duration cell cycles. Thus, we are able to charac-
terize some hematological diseases, especially those which exhibit a periodic behavior of all
the circulating blood cells.
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[10] J. Dieudonné, Foundations of Modern Analysis, Academic Press, New-York, 1960.
[11] P. Fortin and M. C. Mackey, Periodic chronic myelogenous leukemia: Spectral analysis
of blood cell counts and etiological implications, Brit. J. Haematol. 104 (1999), 336–345.
[12] A. C. Fowler and M. C. Mackey, Relaxation oscillations in a class of delay differential
equations, SIAM J. Appl. Math. 63 (2002), 299–323.
[13] J. K. Hale, Theory of Functional Differential Equations, Springer-Verlag, New York,
1977.
24
M. Adimy, F. Crauste and S. Ruan Hematopoiesis Model
[14] C. Haurie, D. C. Dale and M. C. Mackey, Cyclical neutropenia and other periodic
hematological diseases: A review of mechanisms and mathematical models, Blood 92
(1998), 2629–2640.
[15] Y. Kuang, Nonoccurrence of stability switching in systems of differential equations with
distributed delays, Quart. Appl. Math. LII (3) (1994), 569–578.
[16] M. C. Mackey, Unified hypothesis of the origin of aplastic anaemia and periodic
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